Lung Cancer: Screening with low-dose CT scan

Lung cancer is the leading cause of cancer death worldwide. According to a review by the European Respiratory Review (Hardavella et al., 2025), screening with low-dose CT scans has a clear benefit over risk.

Lung cancer screening with low-dose CT is a proven health intervention, with a clear benefit over risk. Early diagnosis shifts lung cancer to Stage I, where the disease can be radically eliminated, according to Athanasios N. Chalazonitis, MD, MPH, PhD, President of the Hellenic Radiological Society.